Global Pharma, Biotech and Diagnostics Manufacturing and Supply Partnering Terms and Agreements Report 2021: Detailed Access to Deals Entered Into by the Leading 50 Bigpharma Companies
27 avr. 2021 04h48 HE
|
Research and Markets
Dublin, April 27, 2021 (GLOBE NEWSWIRE) -- The "Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021" report has been added to...
Progenity to Present Two Abstracts for Novel Ingestible Drug Delivery Technologies at Digestive Disease Week 2021
26 avr. 2021 07h30 HE
|
Progenity, Inc.
SAN DIEGO, April 26, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing...
Next Generation Cancer Diagnostics Market Report 2021: Global Next Generation Cancer Diagnostics Market to Grow $15,738.27 Million by 2025, at a CAGR of 22.54%
23 avr. 2021 05h03 HE
|
Research and Markets
Dublin, April 23, 2021 (GLOBE NEWSWIRE) -- The "Next Generation Cancer Diagnostics Market Research Report by Technology, by Cancer Type, by Function, by Application - Global Forecast to 2025 -...
Global Antimicrobial Resistance Diagnostic Markets, Strategies and Trends Report 2021-2025: Will Diagnostics Solve the Problem - Multiple Diagnostic Technologies Create New Global Race
22 avr. 2021 04h03 HE
|
Research and Markets
Dublin, April 22, 2021 (GLOBE NEWSWIRE) -- The "Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, with Executive Guides and Customization - 2021 to 2025"...
Persbericht Biocartis Group NV: BIOCARTIS Q1 2021 BUSINESS UPDATE
22 avr. 2021 01h01 HE
|
Biocartis NV
PERSBERICHT: GEREGLEMENTEERDE INFORMATIE22 april 2021, 07:01 CEST BIOCARTIS Q1 2021 BUSINESS UPDATE70% Cartridgevolume groei in Q1 2021; Nieuw partnership met SkylineDx in Melanoom Testing Mechelen,...
Press release Biocartis Group NV: BIOCARTIS Q1 2021 BUSINESS UPDATE
22 avr. 2021 01h01 HE
|
Biocartis NV
PRESS RELEASE: REGULATED INFORMATION22 April 2021, 07:01 CEST BIOCARTIS Q1 2021 BUSINESS UPDATE70% Cartridge Volume Growth in Q1 2021; New Partnership with SkylineDx on Melanoma Testing Mechelen,...
Global Pharma, Biotech and Diagnostics Partnering Directory 2014-2021: Access to Over 2,200 Agreements by the World's Leading Life Science Companies
20 avr. 2021 05h28 HE
|
Research and Markets
Dublin, April 20, 2021 (GLOBE NEWSWIRE) -- The "Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2021" report has been added to ResearchAndMarkets.com's...
Persbericht Biocartis Group NV: Biocartis kondigt US FDA 510(k) indiening aan van zijn Idylla™ MSI Test
20 avr. 2021 01h00 HE
|
Biocartis NV
PERSBERICHT: 20 april 2021, 07:00 CEST Biocartis kondigt US FDA 510(k) indiening aan van zijn Idylla™ MSI TestEerste US FDA Oncologie Assay indiening voor Biocartis Mechelen, België, 20 april...
Press release Biocartis Group NV: Biocartis Announces US FDA 510(k) submission of its Idylla™ MSI Test
20 avr. 2021 01h00 HE
|
Biocartis NV
PRESS RELEASE: 20 April 2021, 07:00 CEST Biocartis Announces US FDA 510(k) submission of its Idylla™ MSI TestFirst US FDA Oncology Assay Submission for Biocartis Mechelen, Belgium, 20 April 2021 –...
Global Lymphedema Diagnostics Industry (2020 to 2027) - Market Trajectory & Analytics
19 avr. 2021 08h38 HE
|
Research and Markets
Dublin, April 19, 2021 (GLOBE NEWSWIRE) -- The "Lymphedema Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19...